speb/financial-data huggingface dataset:
Financial ratios for PHA.V — quarterly report dated 2025-09-30
Total revenue: 14956834.532374103
Gross profit: 2483453.2374100722
Operating income: -1574820.143884892
Net income: -4674100.719424461
Capital expenditures: 5035.971223021583
Operating cash flow: 5035971.223021583
Depreciation & amortization: 1596402.8776978417
Net tangible assets: -26010071.942446046
Owner earnings: -3082733.8129496407
Buffett classification: The Gruesome
Stock price: 0.02158273381294964
Shares outstanding: 55514151
Book value: -8110071.942446046
Market cap (USD): 1198147.143884892
Debt to equity: -3.9358644548922195
Current ratio: 0.3994952295367201
Quick ratio: 0.3994952295367201
Interest coverage ratio: -1.653323262839879
COGS to revenue (%): 83.3958633958634
SG&A to revenue (%): 50.683020683020686
Free cash flow (dilution-adjusted): 4788489.208633093
Buyback yield (%): 0
Retained earnings: -19362589.928057555
Receivables turnover: 1.211891576799767
Capitalized R&D asset: 0
FCF margin (%): 32.01539201539201
Revenue growth (%): -6.4771186245891235
Rule of 40 score: 25.538273390802885
Financial ratios for PHA.V — annual report dated 2025-09-30
Total revenue: 73358992.8057554
Gross profit: 11947482.01438849
Operating income: -6185611.510791367
Net income: -11107913.669064749
Capital expenditures: 49640.287769784176
Operating cash flow: 8784172.661870504
Depreciation & amortization: 5903597.122302159
Net tangible assets: -26010071.942446046
Owner earnings: -5253956.8345323745
Buffett classification: The Gruesome
Stock price: 0.02158273381294964
Shares outstanding: 55514151
Book value: -8110071.942446046
Market cap (USD): 1198147.143884892
Debt to equity: -3.9358644548922195
Current ratio: 0.3994952295367201
Quick ratio: 0.3994952295367201
Interest coverage ratio: -1.5522657519407834
COGS to revenue (%): 83.71367768635565
SG&A to revenue (%): 10.116800203983562
Free cash flow (dilution-adjusted): 7327338.129496403
Buyback yield (%): 0
Retained earnings: -19362589.928057555
Receivables turnover: 5.943981346546197
Capitalized R&D asset: 0
FCF margin (%): 9.98832978650374
Revenue growth (%): -37.395528008692146
Rule of 40 score: -27.407198222188406
Financial ratios for PLMK — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -306345
Net income: 1182055
Capital expenditures: 0
Operating cash flow: -338313
Net tangible assets: 169448286
Owner earnings: 1182055
Return on net tangible assets (%): 0.6975904141042771
Buffett classification: The Gruesome
Stock price: 10.04
P/E ratio: 39.26815270863031
Shares outstanding: 18492875
Book value: 169448286
P/B ratio: 1.0957234763649364
Market cap (USD): 185668464.99999997
Debt to equity: 0
Current ratio: 4.090410153378743
Quick ratio: 4.090410153378743
Free cash flow (dilution-adjusted): -338313
Buyback yield (%): 0
Retained earnings: -6265813
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.17371589310485275
Rule of 40 score: 0
Financial ratios for PLMK — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -237782
Net income: 1629227
Capital expenditures: 0
Operating cash flow: -201619
Net tangible assets: 171077513
Owner earnings: 1629227
Return on net tangible assets (%): 0.9523326423385637
Buffett classification: The Gruesome
Stock price: 10.28
P/E ratio: 67.62279806863914
Shares outstanding: 18492875
Book value: 171077513
P/B ratio: 1.1112316964766726
Market cap (USD): 190106755
Debt to equity: 0
Current ratio: 3.0987242488372373
Quick ratio: 3.0987242488372373
Free cash flow (dilution-adjusted): -201619
Buyback yield (%): 0
Retained earnings: -6503595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.13360227142852593
Rule of 40 score: 0
Financial ratios for PLMK — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -236000
Net income: 1679645
Capital expenditures: 0
Operating cash flow: -156615
Net tangible assets: 172757158
Owner earnings: 1679645
Return on net tangible assets (%): 0.9722578325813858
Buffett classification: The Gruesome
Stock price: 10.32
P/E ratio: 42.49600806247797
Shares outstanding: 18492875
Book value: 172757158
P/B ratio: 1.1047094789554248
Market cap (USD): 190846470
Debt to equity: 0.0014471180406892316
Current ratio: 1.3093875603845888
Quick ratio: 1.3093875603845888
Free cash flow (dilution-adjusted): -156615
Buyback yield (%): 0
Retained earnings: -6737121
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1313613120830955
Rule of 40 score: 0
Financial ratios for PLMK — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -241141
Net income: 1560894
Capital expenditures: 0
Operating cash flow: -172959
Net tangible assets: 174318052
Owner earnings: 1560894
Return on net tangible assets (%): 0.8954287763610392
Buffett classification: The Gruesome
Stock price: 10.46
P/E ratio: 31.963184717459423
Shares outstanding: 18492875
Book value: 174318052
P/B ratio: 1.1096697690265607
Market cap (USD): 193435472.50000003
Debt to equity: 0.001434160129324988
Current ratio: 0.8475864075786479
Quick ratio: 0.8475864075786479
Free cash flow (dilution-adjusted): -172959
Buyback yield (%): 0
Retained earnings: -6967867
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.13306676533527687
Rule of 40 score: 0
Financial ratios for PLMK — annual report dated 2025-12-31
Total revenue: 0
Operating income: -1021268
Net income: 6051821
Capital expenditures: 0
Operating cash flow: -869506
Net tangible assets: 174318052
Owner earnings: 6051821
Return on net tangible assets (%): 3.471712155204672
Buffett classification: The Gruesome
Stock price: 10.46
P/E ratio: 31.963184717459423
Shares outstanding: 18492875
Book value: 174318052
P/B ratio: 1.1096697690265607
Market cap (USD): 193435472.50000003
Debt to equity: 0.001434160129324988
Current ratio: 0.8475864075786479
Quick ratio: 0.8475864075786479
Free cash flow (dilution-adjusted): -869506
Buyback yield (%): 0
Retained earnings: -6967867
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5635575422695748
Rule of 40 score: 0
Financial ratios for PSNY — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 5611823.2044198895
Buffett classification: The Gruesome
Stock price: 351
Shares outstanding: 143907518
Market cap (USD): 50511538818
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PSNY — annual report dated 2022-12-31
Total revenue: 233571100.47846892
Gross profit: 9676746.411483254
Operating income: -87271387.55980861
Net income: -45838947.368421055
Capital expenditures: 3087942.583732058
Operating cash flow: -103440287.08133972
Depreciation & amortization: 13474258.373205742
Net tangible assets: -141958851.67464116
Owner earnings: -35452631.57894737
Buffett classification: The Gruesome
Stock price: 159.3
Shares outstanding: 143907518
Book value: -8605837.320574164
Market cap (USD): 22924467617.4
Debt to equity: -16.02414073011531
Current ratio: 0.673633500046129
Quick ratio: 0.47588961433048044
Interest coverage ratio: -11.771054635569266
COGS to revenue (%): 95.85704464650784
R&D to revenue (%): 7.166286056559726
SG&A to revenue (%): 35.42246902472859
Free cash flow (dilution-adjusted): -171052153.11004785
Buyback yield (%): 0
Retained earnings: -352137033.492823
Inventory turnover: 3.712895577906353
Receivables turnover: 5.5489404848239605
Capitalized R&D asset: 16738373.205741627
ROCI (R&D-adjusted, %): -79.70243767688679
FCF margin (%): -73.23344059245711
Rule of 40 score: -73.23344059245711
Financial ratios for PSNY — annual report dated 2023-12-31
Total revenue: 237521063.1895687
Gross profit: -41137111.334002
Operating income: -152742226.68004012
Net income: -118543129.38816449
Capital expenditures: 13602908.726178534
Operating cash flow: -189953961.88565695
Depreciation & amortization: 11579237.713139417
Net tangible assets: -267773119.35807422
Owner earnings: -120566800.4012036
Buffett classification: The Gruesome
Stock price: 67.8
Shares outstanding: 143907518
Book value: -125475526.57973921
Market cap (USD): 9756929720.4
Debt to equity: -2.8679039257676515
Current ratio: 0.6273858660006227
Quick ratio: 0.3713018110829176
Interest coverage ratio: -7.404000427853247
COGS to revenue (%): 117.31935297930607
R&D to revenue (%): 6.6416534879449
SG&A to revenue (%): 39.87090834999588
Free cash flow (dilution-adjusted): -247424774.3229689
Buyback yield (%): 0
Retained earnings: -487633600.8024072
Inventory turnover: 2.994787029231874
Receivables turnover: 4.794800824481763
Capitalized R&D asset: 26990036.025780693
ROCI (R&D-adjusted, %): -156.9817522551468
Rosenberg metric: -3.035770389445911
FCF margin (%): -104.16961384409767
Revenue growth (%): 1.6911179092825697
Rule of 40 score: -102.4784959348151
Financial ratios for PSNY — annual report dated 2024-12-31
Total revenue: 184597186.93284938
Gross profit: -79506987.29582578
Operating income: -161710617.0598911
Net income: -186016061.70598912
Capital expenditures: 13417513.611615246
Operating cash flow: -89946370.23593467
Depreciation & amortization: 5056170.598911071
Net tangible assets: -396498094.3738657
Owner earnings: -194377404.7186933
Buffett classification: The Gruesome
Stock price: 31.5
Shares outstanding: 143907518
Book value: -302047186.93284935
Market cap (USD): 4533086817
Debt to equity: -1.5244345903333576
Current ratio: 0.4847835890565024
Quick ratio: 0.2571151591648397
Interest coverage ratio: -5.313021001037529
COGS to revenue (%): 143.07053028102098
R&D to revenue (%): 1.8852054873981263
SG&A to revenue (%): 41.24239711620092
Free cash flow (dilution-adjusted): -122341560.7985481
Buyback yield (%): 0
Retained earnings: -627187295.8257713
Inventory turnover: 2.696436132118911
Receivables turnover: 5.10975778233818
Capitalized R&D asset: 19573167.860751037
Rosenberg metric: -2.4322715115677966
FCF margin (%): -66.27487819901184
Revenue growth (%): -22.2817612661493
Rule of 40 score: -88.55663946516114
Financial ratios for PSNY — quarterly report dated 2025-03-31
Total revenue: 63136863.136863135
Gross profit: 6493506.493506494
Net income: -16583416.583416583
Capital expenditures: 0
Owner earnings: -16583416.583416583
Buffett classification: The Gruesome
Stock price: 31.5
Shares outstanding: 143907518
Market cap (USD): 4533086817
COGS to revenue (%): 89.71518987341773
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PSNY — quarterly report dated 2025-06-30
Total revenue: 83485216.47307286
Gross profit: -81111298.83843717
Net income: -108456071.80570221
Capital expenditures: 0
Net tangible assets: -538930200.6335797
Owner earnings: -108456071.80570221
Buffett classification: The Gruesome
Stock price: 32.1
Shares outstanding: 143907518
Book value: -450475501.5839493
Market cap (USD): 4619431327.8
Debt to equity: -1.3233823323612288
Current ratio: 0.42558894844872536
Quick ratio: 0.2707131046292
COGS to revenue (%): 197.15648142877924
Buyback yield (%): 0
Retained earnings: -855827138.3315734
Inventory turnover: 1.934624631221756
Receivables turnover: 1.8850633635745877
Capitalized R&D asset: 0
Revenue growth (%): 32.2289583695347
Rule of 40 score: 32.2289583695347
Financial ratios for PSNY — annual report dated 2025-12-31
Total revenue: 332764853.10119694
Gross profit: -117944504.89662677
Operating income: -216159738.84657237
Net income: -256499564.74428728
Capital expenditures: 16724265.505984766
Operating cash flow: -99563547.33405876
Depreciation & amortization: 5737105.549510337
Net tangible assets: -633574211.0990207
Owner earnings: -267486724.7007617
Buffett classification: The Gruesome
Stock price: 21.37
Shares outstanding: 143907518
Book value: -557368988.0304679
Market cap (USD): 3075303659.6600003
Debt to equity: -1.267151300187946
Current ratio: 0.4330784962858479
Quick ratio: 0.29566863999873716
Interest coverage ratio: -5.294164050465586
COGS to revenue (%): 135.44379876583866
R&D to revenue (%): 2.5386930289273537
SG&A to revenue (%): 26.612818575139087
Free cash flow (dilution-adjusted): -149051251.36017412
Buyback yield (%): 0
Retained earnings: -1008578346.0282917
Inventory turnover: 4.855375645162992
Receivables turnover: 5.977842892719332
Capitalized R&D asset: 15985360.020537827
Rosenberg metric: -11.045148473554809
FCF margin (%): -44.79176510712993
Revenue growth (%): 80.26539766407507
Rule of 40 score: 35.473632556945134
Financial ratios for PSNY — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: -633574211.0990207
Buffett classification: The Gruesome
Stock price: 21.37
Shares outstanding: 143907518
Book value: -557368988.0304679
Market cap (USD): 3075303659.6600003
Debt to equity: -1.267151300187946
Current ratio: 0.4330784962858479
Quick ratio: 0.29566863999873716
Buyback yield (%): 0
Retained earnings: -1008578346.0282917
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RELAXO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.849663721482264
Shares outstanding: 248938586
Market cap (USD): 3447715703.401293
Buyback yield (%): 0
Retained earnings: 8360807.068442569
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RELAXO.NS — annual report dated 2023-03-31
Total revenue: 336679658.952497
Gross profit: 173230207.06455544
Operating income: 26281364.190012183
Net income: 18814859.926918395
Capital expenditures: 21437271.61997564
Operating cash flow: 48729598.05115713
Depreciation & amortization: 15237515.22533496
Net tangible assets: 222059683.3130329
Owner earnings: 12615103.53227771
Return on net tangible assets (%): 5.680951780199769
Capex to operating income (%): 81.56833665477127
Buffett classification: The Gruesome
Stock price: 10.233495736906212
P/E ratio: 135.39893299645237
Shares outstanding: 248938586
Book value: 225950060.90133983
P/B ratio: 11.27466816525808
Market cap (USD): 2547511958.5824604
Debt to equity: 0.0884504460796205
Current ratio: 2.53613088282163
Quick ratio: 1.3382556039519815
Effective tax rate (%): 26.44635969715728
Interest coverage ratio: 11.302776322682034
COGS to revenue (%): 48.54746865209432
SG&A to revenue (%): 9.779533598153494
Free cash flow (dilution-adjusted): 26136419.00121803
Buyback yield (%): 0
Retained earnings: 9822168.08769793
Inventory turnover: 2.3802192344531554
Receivables turnover: 10.224680032551602
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.659835782109935
FCF margin (%): 7.762993191372361
Rule of 40 score: 7.762993191372361
Financial ratios for RELAXO.NS — annual report dated 2024-03-31
Total revenue: 346996042.6909701
Gross profit: 199748171.24355438
Operating income: 31871927.089579087
Net income: 24040052.764120396
Capital expenditures: 29393212.615421515
Operating cash flow: 28195227.24547308
Depreciation & amortization: 17686772.994363833
Net tangible assets: 237247871.44741577
Owner earnings: 12333613.143062714
Return on net tangible assets (%): 5.198619093110122
Capex to operating income (%): 92.22289111295056
Buffett classification: The Gruesome
Stock price: 9.706693857965451
P/E ratio: 100.51436523231013
Shares outstanding: 248938586
Book value: 239970020.38613743
P/B ratio: 10.069468843852267
Market cap (USD): 2416370643.736804
Debt to equity: 0.10242815237543162
Current ratio: 2.3994417172008853
Quick ratio: 1.2466839926845699
Effective tax rate (%): 25.55056263230215
Interest coverage ratio: 14.335490830636461
COGS to revenue (%): 42.43502902958253
SG&A to revenue (%): 11.204727674868677
Free cash flow (dilution-adjusted): -2395970.73989687
Buyback yield (%): 0
Retained earnings: 11257944.597673582
Inventory turnover: 2.0506012024048097
Receivables turnover: 8.088555934477553
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.111407817868631
FCF margin (%): -0.6904893558197402
Revenue growth (%): 3.0641541489528126
Rule of 40 score: 2.3736647931330723
Financial ratios for RELAXO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 238056617.29574773
Buffett classification: The Gruesome
Stock price: 9.627926421404682
Shares outstanding: 248938586
Book value: 240198279.98088866
P/B ratio: 9.978266245899928
Market cap (USD): 2396762389.4565215
Debt to equity: 0.10534874237918586
Current ratio: 2.42498413202158
Quick ratio: 1.0970128530625198
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RELAXO.NS — quarterly report dated 2025-03-31
Total revenue: 81266074.35118073
Gross profit: 44632920.27121814
Operating income: 8496609.773205517
Net income: 6572363.806406359
Capital expenditures: 0
Depreciation & amortization: 4602525.134440028
Net tangible assets: 243675473.4627075
Owner earnings: 11174888.940846387
Return on net tangible assets (%): 4.585971982345039
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.719220445792975
P/E ratio: 44.68696877571163
Shares outstanding: 248938586
Book value: 245273556.231003
P/B ratio: 4.789737967885739
Market cap (USD): 1174796064.797993
Debt to equity: 0.10129309317610949
Current ratio: 2.7385652810434316
Quick ratio: 1.5017301805598686
Effective tax rate (%): 25.39808917197452
Interest coverage ratio: 13.434380776340111
COGS to revenue (%): 45.07804071063799
Buyback yield (%): 0
Retained earnings: 13389057.750759877
Inventory turnover: 0.561989992646927
Receivables turnover: 2.2276878705335688
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1440745787640862
Rule of 40 score: 0
Financial ratios for RELAXO.NS — annual report dated 2025-03-31
Total revenue: 326117605.79845685
Gross profit: 191802665.41968668
Operating income: 26136310.498012625
Net income: 19912321.72083236
Capital expenditures: 13286181.903203178
Operating cash flow: 47464344.166471824
Depreciation & amortization: 18521159.691372454
Net tangible assets: 243675473.4627075
Owner earnings: 25147299.50900164
Return on net tangible assets (%): 10.319996161965076
Capex to operating income (%): 50.83419063380597
Buffett classification: The Good
Stock price: 4.719220445792975
P/E ratio: 58.998447356789946
Shares outstanding: 248938586
Book value: 245273556.231003
P/B ratio: 4.789737967885739
Market cap (USD): 1174796064.797993
Debt to equity: 0.10129309317610949
Current ratio: 2.7385652810434316
Quick ratio: 1.5017301805598686
Effective tax rate (%): 25.901596554574326
Interest coverage ratio: 10.821393998063892
COGS to revenue (%): 41.18604392728732
SG&A to revenue (%): 10.498958635794969
Free cash flow (dilution-adjusted): 33923310.731821366
Buyback yield (%): 0
Retained earnings: 13389057.750759877
Inventory turnover: 2.0605283451998777
Receivables turnover: 8.939625060086525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.671446802067788
FCF margin (%): 10.402170912779923
Revenue growth (%): -6.016909221961162
Rule of 40 score: 4.38526169081876
Financial ratios for RELAXO.NS — quarterly report dated 2025-06-30
Total revenue: 76584366.95530073
Gross profit: 47360168.49988299
Operating income: 6997425.696232156
Net income: 5721975.193072783
Capital expenditures: 0
Depreciation & amortization: 4639597.472501756
Owner earnings: 10361572.66557454
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.057453779545987
P/E ratio: 55.00702773776074
Shares outstanding: 248938586
Market cap (USD): 1258995392.6405337
Effective tax rate (%): 25.80791989076013
Interest coverage ratio: 11.477927063339731
COGS to revenue (%): 38.15948295619489
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -5.760961672208518
Rule of 40 score: -5.760961672208518
Financial ratios for RELAXO.NS — quarterly report dated 2025-09-30
Total revenue: 70861330.32694475
Gross profit: 43235625.70462232
Operating income: 4712514.092446448
Net income: 4076662.908680947
Capital expenditures: 0
Depreciation & amortization: 4437429.537767757
Net tangible assets: 236669673.0552424
Owner earnings: 8514092.446448704
Return on net tangible assets (%): 3.5974581519202005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.027621195039458
P/E ratio: 76.45035522309183
Shares outstanding: 248938586
Book value: 237822998.87260428
P/B ratio: 5.26260671663293
Market cap (USD): 1251568911.236753
Debt to equity: 0.10214317204632399
Current ratio: 2.153432154247608
Quick ratio: 1.0773775007248478
Effective tax rate (%): 25.977482088024566
Interest coverage ratio: 8.023032629558541
COGS to revenue (%): 38.98558564291851
Buyback yield (%): 0
Inventory turnover: 0.4126572472676445
Receivables turnover: 2.301079992678016
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8030375575311324
Revenue growth (%): -7.472852301170407
Rule of 40 score: -7.472852301170407
Financial ratios for RELAXO.NS — quarterly report dated 2025-12-31
Total revenue: 74415729.08544058
Gross profit: 42818313.46775092
Operating income: 3369722.6244847947
Net income: 2956444.246407486
Capital expenditures: 0
Depreciation & amortization: 4360031.190820987
Owner earnings: 7316475.437228473
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.504845716831904
P/E ratio: 58.022664449708884
Shares outstanding: 248938586
Market cap (USD): 1121429922.8962905
Effective tax rate (%): 26.11358574610245
Interest coverage ratio: 5.718336483931948
COGS to revenue (%): 42.46066793407482
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.01599213858433
Rule of 40 score: 5.01599213858433
Financial ratios for SACI.PA — annual report dated 2021-09-30
Total revenue: 222838372.09302327
Gross profit: 83350000
Operating income: 2944186.0465116277
Net income: 2797674.418604651
Capital expenditures: 3923255.8139534886
Operating cash flow: 12236046.511627907
Depreciation & amortization: 9497674.418604651
Net tangible assets: 23459302.325581394
Owner earnings: 8372093.023255814
Return on net tangible assets (%): 35.687732342007436
Capex to operating income (%): 133.25434439178517
Buffett classification: The Gruesome
Stock price: 29.546511627906977
P/E ratio: 22.90947012468828
Shares outstanding: 2169232
Book value: 89311627.90697676
P/B ratio: 0.7176359900010414
Market cap (USD): 64093238.511627905
Debt to equity: 0.26761535256744085
Current ratio: 1.2400182272434437
Quick ratio: 0.9763517229458997
Effective tax rate (%): -0.7115948095437422
Interest coverage ratio: 20.419354838709676
COGS to revenue (%): 62.59620853575175
SG&A to revenue (%): 15.595305806168827
Free cash flow (dilution-adjusted): 8300000
Buyback yield (%): 0
Retained earnings: 2797674.418604651
Inventory turnover: 7.148986889153755
Receivables turnover: 4.761503677201352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0065902748916464
FCF margin (%): 3.724672695300066
Rule of 40 score: 3.724672695300066
Financial ratios for SLDE — quarterly report dated 2025-06-30
Total revenue: 261607000
Net income: 70072000
Capital expenditures: 908000
Operating cash flow: 253617000
Depreciation & amortization: 3015000
Net tangible assets: 861557000
Owner earnings: 72179000
Return on net tangible assets (%): 8.377739371858159
Buffett classification: The Gruesome
Stock price: 21.66
P/E ratio: 15.26282188749808
Shares outstanding: 114559246
Book value: 868060000
P/B ratio: 2.8585043296085524
Market cap (USD): 2481353268.36
Debt to equity: 0.051441144621339537
Effective tax rate (%): 27.233454832445453
COGS to revenue (%): 0
SG&A to revenue (%): 14.500758771745403
Free cash flow (dilution-adjusted): 249709000
Buyback yield (%): 0
Retained earnings: 471766000
Receivables turnover: 0.6821849151463947
Capitalized R&D asset: 0
FCF margin (%): 95.4519565607954
Revenue growth (%): -7.097477565138338
Rule of 40 score: 88.35447899565706
Financial ratios for SLDE — quarterly report dated 2025-09-30
Total revenue: 265693000
Net income: 110997000
Capital expenditures: 818000
Operating cash flow: 25273000
Depreciation & amortization: 3131000
Net tangible assets: 959618000
Owner earnings: 113310000
Return on net tangible assets (%): 11.807823529779558
Buffett classification: The Gruesome
Stock price: 15.78
P/E ratio: 6.60793100858275
Shares outstanding: 114559246
Book value: 964220000
P/B ratio: 1.8748261826968948
Market cap (USD): 1807744901.8799999
Debt to equity: 0.04662628860633465
Effective tax rate (%): 24.499540863177227
COGS to revenue (%): 0
SG&A to revenue (%): 16.938722510566706
Free cash flow (dilution-adjusted): 21499000
Buyback yield (%): 0
Retained earnings: 582763000
Receivables turnover: 0.7530276363038605
Capitalized R&D asset: 0
FCF margin (%): 8.091669709025078
Revenue growth (%): 1.5618848119507507
Rule of 40 score: 9.65355452097583
Financial ratios for SLDE — annual report dated 2025-12-31
Total revenue: 1155901000
Net income: 443958000
Capital expenditures: 2857000
Operating cash flow: 797432000
Depreciation & amortization: 12444000
Net tangible assets: 1110539000
Owner earnings: 453545000
Return on net tangible assets (%): 40.84007855644872
Buffett classification: The Gruesome
Stock price: 19.48
P/E ratio: 5.02663340243897
Shares outstanding: 114559246
Book value: 1113241000
P/B ratio: 2.004610063840624
Market cap (USD): 2231614112.08
Debt to equity: 0.03892777933978357
Effective tax rate (%): 24.655699979125618
COGS to revenue (%): 0
SG&A to revenue (%): 15.204589320365672
Free cash flow (dilution-adjusted): 782505000
Buyback yield (%): 1.792424585571274
Retained earnings: 753149000
Receivables turnover: 3.9255207873448845
Capitalized R&D asset: 0
FCF margin (%): 67.69654148581928
Revenue growth (%): 36.499987010134454
Rule of 40 score: 104.19652849595374
Financial ratios for SLDE — quarterly report dated 2025-12-31
Total revenue: 347007000
Net income: 170386000
Capital expenditures: 543000
Operating cash flow: 421730000
Depreciation & amortization: 3258000
Net tangible assets: 1110539000
Owner earnings: 173101000
Return on net tangible assets (%): 15.587115805928473
Buffett classification: The Gruesome
Stock price: 19.48
P/E ratio: 5.02663340243897
Shares outstanding: 114559246
Book value: 1113241000
P/B ratio: 2.004610063840624
Market cap (USD): 2231614112.08
Debt to equity: 0.03892777933978357
Effective tax rate (%): 23.256463381677325
COGS to revenue (%): 0
SG&A to revenue (%): 14.821603022417415
Free cash flow (dilution-adjusted): 418087000
Buyback yield (%): 0.896212292785637
Retained earnings: 753149000
Receivables turnover: 1.1784600859884942
Capitalized R&D asset: 0
FCF margin (%): 120.48373663931851
Revenue growth (%): 30.604494661131454
Rule of 40 score: 151.08823130044996
Financial ratios for SNTG — annual report dated 2021-12-31
Capital expenditures: 3136.1067503924646
Buffett classification: The Gruesome
Stock price: 6.15
Shares outstanding: 2805325
Market cap (USD): 17252748.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SNTG — annual report dated 2022-12-31
Total revenue: 23185.632183908045
Gross profit: 20623.419540229886
Operating income: -369397.5574712644
Net income: -368090.0862068966
Capital expenditures: 0
Operating cash flow: -959692.5287356322
Depreciation & amortization: 8251.149425287356
Net tangible assets: 2023777.155172414
Owner earnings: -359838.9367816092
Return on net tangible assets (%): -17.78056125704972
Buffett classification: The Gruesome
Stock price: 1.92
Shares outstanding: 2805325
Book value: 2036632.7586206899
P/B ratio: 2.64467119916495
Market cap (USD): 5386224
Debt to equity: 0.011394244105311306
Current ratio: 35.43032336323457
Quick ratio: 35.43032336323457
COGS to revenue (%): 11.050863842550134
SG&A to revenue (%): 1682.166670797908
Free cash flow (dilution-adjusted): -964627.2988505748
Buyback yield (%): 0
Retained earnings: -5956978.591954023
Receivables turnover: 0.01542097880766932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.037019214950522
FCF margin (%): -4160.452866668319
Rule of 40 score: -4160.452866668319
Financial ratios for SNTG — annual report dated 2023-12-31
Total revenue: 20612.37693389592
Gross profit: 18840.646976090015
Operating income: -248038.67791842474
Net income: -267690.1547116737
Capital expenditures: 3295.780590717299
Operating cash flow: -256954.14908579463
Depreciation & amortization: 14858.227848101265
Net tangible assets: 1710694.0928270041
Owner earnings: -256127.70745428972
Return on net tangible assets (%): -14.972151276387843
Buffett classification: The Gruesome
Stock price: 5
Shares outstanding: 2805325
Book value: 1720097.6090014065
P/B ratio: 8.154551768805192
Market cap (USD): 14026625
Debt to equity: 0.005906020117590552
Current ratio: 34.90207754992388
Quick ratio: 34.90207754992388
COGS to revenue (%): 8.59546651746114
SG&A to revenue (%): 1294.7527873684785
Free cash flow (dilution-adjusted): -260249.92967651194
Buyback yield (%): 0
Retained earnings: -6098994.092827004
Receivables turnover: 0.015629247469341436
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.025265686394661
FCF margin (%): -1262.5905809462722
Revenue growth (%): -11.09849077912177
Rule of 40 score: -1273.689071725394
Financial ratios for SNTG — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1393773.2876712328
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 2805325
Book value: 1400890.6849315069
P/B ratio: 3.6245784946798034
Market cap (USD): 5077638.25
Debt to equity: 0.014335204745474063
Current ratio: 7.445353653845542
Quick ratio: 7.445353653845542
Buyback yield (%): 0
Retained earnings: -6214887.534246575
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SNTG — annual report dated 2024-12-31
Total revenue: 14726.986301369863
Gross profit: 13620.95890410959
Operating income: -237877.12328767125
Net income: -274634.38356164383
Capital expenditures: 0
Operating cash flow: -239503.42465753425
Depreciation & amortization: 15206.301369863015
Net tangible assets: 1393773.2876712328
Owner earnings: -259428.08219178082
Return on net tangible assets (%): -18.61336305456411
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 2805325
Book value: 1400890.6849315069
P/B ratio: 3.6245784946798034
Market cap (USD): 5077638.25
Debt to equity: 0.014335204745474063
Current ratio: 7.445353653845542
Quick ratio: 7.445353653845542
COGS to revenue (%): 7.5102086375770885
SG&A to revenue (%): 1616.6910061670403
Free cash flow (dilution-adjusted): -239503.42465753425
Buyback yield (%): 0
Retained earnings: -6214887.534246575
Receivables turnover: 0.10262286975953448
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.278236754631855
FCF margin (%): -1626.2894509194753
Revenue growth (%): -28.552702346752916
Rule of 40 score: -1654.8421532662283
Financial ratios for SNTG — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1306702.0920502092
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 2805325
Book value: 1313070.571827057
P/B ratio: 3.9310895474701524
Market cap (USD): 5161798
Debt to equity: 0.010944886707150806
Current ratio: 5.862082071723327
Quick ratio: 5.862082071723327
Buyback yield (%): 0
Retained earnings: -6438861.366806136
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOUC.L — annual report dated 2021-12-31
Capital expenditures: 622047.2440944882
Buffett classification: The Gruesome
Stock price: 0.0024324324324324323
Shares outstanding: 366254953
Market cap (USD): 890890.4262162162
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOUC.L — annual report dated 2022-12-31
Total revenue: 33247794.117647056
Gross profit: 16472058.823529411
Operating income: 12441911.764705881
Net income: 6837499.999999999
Capital expenditures: 558088.2352941176
Operating cash flow: 13678676.470588235
Depreciation & amortization: 4732352.94117647
Net tangible assets: 49560294.11764705
Owner earnings: 11011764.705882352
Return on net tangible assets (%): 22.21892525444349
Capex to operating income (%): 4.485550499379469
Buffett classification: The Great
Stock price: 0.0059036144578313255
P/E ratio: 0.31623079133939785
Shares outstanding: 366254953
Book value: 49560294.11764705
P/B ratio: 0.04362823252522271
Market cap (USD): 2162228.0357831325
Debt to equity: 0.11054568113705826
Current ratio: 2.1590087764584407
Quick ratio: 2.1590087764584407
Effective tax rate (%): 0
Interest coverage ratio: 10.242736077481839
COGS to revenue (%): 50.45668664440366
SG&A to revenue (%): 11.814140699294514
Free cash flow (dilution-adjusted): -9190441.176470587
Buyback yield (%): 0
Retained earnings: -10731617.647058822
Receivables turnover: 12.09334046536507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.09350652588539
FCF margin (%): -27.642258442621138
Rule of 40 score: -27.642258442621138
Financial ratios for SOUC.L — annual report dated 2023-12-31
Total revenue: 14631060.606060605
Gross profit: -340909.0909090909
Operating income: -5569696.96969697
Net income: -35467424.24242424
Capital expenditures: 0
Operating cash flow: 2805303.0303030303
Depreciation & amortization: 7193181.818181817
Net tangible assets: 19553787.87878788
Owner earnings: -28274242.424242426
Return on net tangible assets (%): -144.597264732091
Buffett classification: The Gruesome
Stock price: 0.0015189873417721517
Shares outstanding: 366254953
Book value: 19553787.878787875
P/B ratio: 0.028451604411228848
Market cap (USD): 556336.6374683543
Debt to equity: 0.799387857890047
Current ratio: 0.37005180825914197
Quick ratio: 0.37005180825914197
Interest coverage ratio: -2.6734545454545455
COGS to revenue (%): 102.33003676280225
SG&A to revenue (%): 29.513798995495264
Free cash flow (dilution-adjusted): -29497727.272727273
Buyback yield (%): 0
Retained earnings: -46524242.42424242
Receivables turnover: 9.050140581068417
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.502699055330634
FCF margin (%): -201.61031429607004
Revenue growth (%): -55.99389073967219
Rule of 40 score: -257.6042050357422
Financial ratios for SOUC.L — quarterly report dated 2024-09-30
Capital expenditures: 1484444.4444444443
Buffett classification: The Gruesome
Stock price: 0.0010666666666666667
Shares outstanding: 366254953
Market cap (USD): 390671.9498666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOUC.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0007499999999999999
Shares outstanding: 366254953
Market cap (USD): 274691.21475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOUC.L — annual report dated 2024-12-31
Total revenue: 11244755.244755246
Gross profit: -162937.06293706293
Operating income: -4206993.006993007
Net income: -8055944.055944056
Capital expenditures: 618181.8181818182
Operating cash flow: 2692307.6923076925
Depreciation & amortization: 4954545.454545455
Net tangible assets: 10319580.41958042
Owner earnings: -3719580.4195804195
Return on net tangible assets (%): -36.04391136409839
Buffett classification: The Gruesome
Stock price: 0.0007499999999999999
Shares outstanding: 366254953
Book value: 10319580.419580422
P/B ratio: 0.026618447997052236
Market cap (USD): 274691.21475
Debt to equity: 1.435047773937792
Current ratio: 0.18762631201512484
Quick ratio: 0.18762631201512484
Interest coverage ratio: -1.9596091205211723
COGS to revenue (%): 101.44900497512437
SG&A to revenue (%): 26.884328358208954
Free cash flow (dilution-adjusted): 1816783.2167832167
Buyback yield (%): 0
Retained earnings: -51001398.6013986
Receivables turnover: 7.805825242718448
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.0173852873762
FCF margin (%): 16.156716417910445
Revenue growth (%): -23.14463354695322
Rule of 40 score: -6.987917129042774
Financial ratios for SOUC.L — quarterly report dated 2025-03-31
Total revenue: 3581118.881118881
Gross profit: 560139.8601398602
Operating income: -228671.3286713287
Net income: -2712587.4125874126
Capital expenditures: 127972.02797202798
Operating cash flow: 786013.986013986
Depreciation & amortization: 1035664.3356643358
Net tangible assets: 7618181.818181818
Owner earnings: -1804895.104895105
Return on net tangible assets (%): -23.691940517716173
Buffett classification: The Gruesome
Stock price: 0.0005194805194805195
Shares outstanding: 366254953
Book value: 7618181.8181818165
P/B ratio: 0.024974766655301746
Market cap (USD): 190262.31324675324
Debt to equity: 1.78612080044061
Current ratio: 0.13500700012727504
Quick ratio: 0.13500700012727504
Interest coverage ratio: -0.46382978723404256
COGS to revenue (%): 84.35852372583481
SG&A to revenue (%): 16.852177309119316
Free cash flow (dilution-adjusted): 678321.6783216783
Buyback yield (%): 0.36754556767832874
Retained earnings: -53713986.013986014
Receivables turnover: 2.3697362332253586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6507648038770257
FCF margin (%): 18.941612966217537
Rule of 40 score: 18.941612966217537
Financial ratios for SOUC.L — quarterly report dated 2025-06-30
Total revenue: 2911678.8321167883
Gross profit: 288321.16788321163
Operating income: -627737.2262773722
Net income: -300000
Capital expenditures: 0
Operating cash flow: -272262.7737226277
Depreciation & amortization: 962773.7226277371
Net tangible assets: 10739416.05839416
Owner earnings: 662773.7226277371
Buffett classification: The Gruesome
Stock price: 0.000410958904109589
Shares outstanding: 366254953
Book value: 10739416.058394156
P/B ratio: 0.01401526240264644
Market cap (USD): 150515.73410958904
Debt to equity: 1.0684428736491542
Current ratio: 0.3182025028441411
Quick ratio: 0.3182025028441411
Interest coverage ratio: -1.440536013400335
COGS to revenue (%): 90.09776886437703
SG&A to revenue (%): 25.64552519428428
Free cash flow (dilution-adjusted): -1954744.525547445
Buyback yield (%): 0
Retained earnings: -56366423.35766423
Receivables turnover: 2.227247347850363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.405392554470954
FCF margin (%): -67.1346202055653
Revenue growth (%): -18.693600274809466
Rule of 40 score: -85.82822048037477
Financial ratios for SOUC.L — quarterly report dated 2025-09-30
Total revenue: 3122302.1582733816
Gross profit: 339568.345323741
Operating income: -510071.9424460432
Net income: 332374.1007194245
Capital expenditures: 0
Operating cash flow: 669784.1726618706
Depreciation & amortization: 1056115.1079136692
Net tangible assets: 10877697.84172662
Owner earnings: 1388489.2086330936
Return on net tangible assets (%): 12.764550264550264
Buffett classification: The Gruesome
Stock price: 0.0004054054054054054
P/E ratio: 0.11168269231967355
Shares outstanding: 366254953
Book value: 10877697.841726616
P/B ratio: 0.013650106839071217
Market cap (USD): 148481.7377027027
Debt to equity: 0.9864417989417993
Current ratio: 0.2528698979591837
Quick ratio: 0.2528698979591837
Interest coverage ratio: -1.237347294938918
COGS to revenue (%): 89.12442396313365
SG&A to revenue (%): 22.92626728110599
Free cash flow (dilution-adjusted): 739568.3453237411
Buyback yield (%): 0
Retained earnings: -55223021.58273382
Receivables turnover: 2.3819978046103185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0288445029474045
FCF margin (%): 23.68663594470046
Revenue growth (%): 7.233741710567385
Rule of 40 score: 30.920377655267842
Financial ratios for SOUC.L — annual report dated 2025-12-31
Total revenue: 13170802.919708028
Gross profit: 1805839.4160583941
Operating income: -1731386.8613138685
Net income: -5480291.970802919
Capital expenditures: 2079562.0437956203
Operating cash flow: 2289781.02189781
Depreciation & amortization: 4054744.525547445
Net tangible assets: 8372992.700729926
Owner earnings: -3505109.4890510943
Return on net tangible assets (%): -41.862087002005055
Buffett classification: The Gruesome
Stock price: 0.0006756756756756757
Shares outstanding: 366254953
Book value: 8372992.700729929
P/B ratio: 0.029555688352178342
Market cap (USD): 247469.56283783785
Debt to equity: 1.2302327608752504
Current ratio: 0.13407598965585835
Quick ratio: 0.13407598965585835
Interest coverage ratio: -0.9793559042113955
COGS to revenue (%): 86.28907115938816
SG&A to revenue (%): 21.99068942584793
Free cash flow (dilution-adjusted): 7299.270072992687
Buyback yield (%): 0
Retained earnings: -58715328.46715328
Receivables turnover: 7.740883740883741
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.327200914665834
FCF margin (%): 0.05542008423852794
Revenue growth (%): 17.128409049642283
Rule of 40 score: 17.18382913388081
Financial ratios for SOUC.L — quarterly report dated 2025-12-31
Total revenue: 3353284.6715328465
Gross profit: 588321.1678832116
Operating income: -327007.29927007295
Net income: -2686131.3868613136
Capital expenditures: 29927.00729927007
Operating cash flow: 1117518.2481751824
Depreciation & amortization: 939416.0583941605
Net tangible assets: 8372992.700729926
Owner earnings: -1776642.335766423
Return on net tangible assets (%): -21.218725481649376
Buffett classification: The Gruesome
Stock price: 0.0006756756756756757
Shares outstanding: 366254953
Book value: 8372992.700729929
P/B ratio: 0.029555688352178342
Market cap (USD): 247469.56283783785
Debt to equity: 1.2302327608752504
Current ratio: 0.13407598965585835
Quick ratio: 0.13407598965585835
Interest coverage ratio: -0.8190127970749543
COGS to revenue (%): 82.4553765781454
SG&A to revenue (%): 23.66129734436221
Free cash flow (dilution-adjusted): 653284.6715328468
Buyback yield (%): 0
Retained earnings: -58715328.46715328
Receivables turnover: 1.970827970827971
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3282403076603257
FCF margin (%): 19.481932956029606
Revenue growth (%): 7.397827037572722
Rule of 40 score: 26.879759993602327
Financial ratios for THNC.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.015748031496063
Shares outstanding: 67408713
Market cap (USD): 472922545.53543305
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THNC.TO — annual report dated 2022-12-31
Total revenue: 37850007.35294117
Gross profit: 28759961.76470588
Operating income: -22752575
Net income: -26780615.44117647
Capital expenditures: 906277.2058823529
Operating cash flow: -19009847.05882353
Depreciation & amortization: 879192.6470588235
Net tangible assets: 64507470.58823529
Owner earnings: -26807700
Return on net tangible assets (%): -41.5575122626016
Buffett classification: The Gruesome
Stock price: 1.3823529411764703
Shares outstanding: 67408713
Book value: 64594437.5
P/B ratio: 1.4425798301358468
Market cap (USD): 93182632.67647058
Debt to equity: 0.022266850855111986
Current ratio: 7.250552084076517
Quick ratio: 7.250552084076517
COGS to revenue (%): 24.0159678265662
R&D to revenue (%): 53.3259007448324
SG&A to revenue (%): 82.77060323828518
Free cash flow (dilution-adjusted): -21984613.970588233
Buyback yield (%): 0
Retained earnings: -47954786.76470588
Receivables turnover: 16.959039493113398
Capitalized R&D asset: 20183857.352941174
ROCI (R&D-adjusted, %): -10.82390188112482
FCF margin (%): -58.08351307725677
Rule of 40 score: -58.08351307725677
Financial ratios for THNC.TO — annual report dated 2023-12-31
Total revenue: 44737878.78787879
Gross profit: 33758333.33333333
Operating income: -8031060.6060606055
Net income: -7409090.909090909
Capital expenditures: 40151.51515151515
Operating cash flow: -4110606.0606060605
Depreciation & amortization: 1016666.6666666666
Net tangible assets: 61992424.24242424
Owner earnings: -6432575.757575758
Return on net tangible assets (%): -10.37639007698888
Buffett classification: The Gruesome
Stock price: 2.4393939393939394
Shares outstanding: 67408713
Book value: 62075757.57575756
P/B ratio: 2.648963337319991
Market cap (USD): 164436405.95454547
Debt to equity: 0.012594581401025142
Current ratio: 6.187085446742099
Quick ratio: 6.187085446742099
COGS to revenue (%): 24.541944660818906
R&D to revenue (%): 32.97151759406645
SG&A to revenue (%): 60.43790429098791
Free cash flow (dilution-adjusted): -8481060.606060605
Buyback yield (%): 0.4146394333178592
Retained earnings: -56816666.666666664
Receivables turnover: 12.328601252609605
Capitalized R&D asset: 28273942.002228163
ROCI (R&D-adjusted, %): -5.4295192875917175
Rosenberg metric: 0.24764203795262596
FCF margin (%): -18.95722559013784
Revenue growth (%): 18.19780738933566
Rule of 40 score: -0.7594182008021768
Financial ratios for THNC.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1333333333333333
Shares outstanding: 67408713
Market cap (USD): 143805254.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THNC.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.0909090909090913
Shares outstanding: 67408713
Market cap (USD): 140945490.81818184
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THNC.TO — annual report dated 2024-12-31
Total revenue: 46812587.41258741
Gross profit: 35183216.78321678
Operating income: -1709090.9090909092
Net income: -165734.26573426573
Capital expenditures: 116083.91608391609
Operating cash flow: 4889510.48951049
Depreciation & amortization: 969230.7692307692
Net tangible assets: 28991608.391608395
Owner earnings: 687412.5874125874
Buffett classification: The Gruesome
Stock price: 2.0909090909090913
Shares outstanding: 67408713
Book value: 29086713.286713287
P/B ratio: 4.845700145934511
Market cap (USD): 140945490.81818184
Debt to equity: 0.04253017262105111
Current ratio: 3.1570783214499536
Quick ratio: 3.1570783214499536
COGS to revenue (%): 24.842400884347647
R&D to revenue (%): 28.45597681575095
SG&A to revenue (%): 50.35254399330764
Free cash flow (dilution-adjusted): 1925174.8251748248
Buyback yield (%): 19.43021648088171
Retained earnings: -52611888.11188811
Receivables turnover: 12.811866028708133
Capitalized R&D asset: 29864659.523207184
ROCI (R&D-adjusted, %): -7.464088573600594
Rosenberg metric: 0.09659730644785368
FCF margin (%): 4.1125153117624205
Revenue growth (%): 4.637476520837508
Rule of 40 score: 8.749991832599928
Financial ratios for THNC.TO — quarterly report dated 2025-03-31
Total revenue: 12478321.678321678
Gross profit: 9211188.811188811
Operating income: -134965.03496503498
Net income: 280419.58041958045
Capital expenditures: 57342.657342657345
Operating cash flow: 2220279.72027972
Depreciation & amortization: 245454.54545454547
Net tangible assets: 29216783.216783218
Owner earnings: 468531.46853146853
Return on net tangible assets (%): 1.6036381043561512
Buffett classification: The Gruesome
Stock price: 1.8181818181818183
P/E ratio: 109.26599364089776
Shares outstanding: 67408713
Book value: 29345454.545454547
P/B ratio: 4.176500185873606
Market cap (USD): 122561296.36363637
Debt to equity: 0.03953388618816128
Current ratio: 3.149020873681945
Quick ratio: 3.149020873681945
COGS to revenue (%): 26.18247029813943
R&D to revenue (%): 27.449002465814843
SG&A to revenue (%): 47.45012329074199
Free cash flow (dilution-adjusted): 1628671.3286713287
Buyback yield (%): 0.39084196498683843
Retained earnings: -52331468.53146853
Receivables turnover: 3.8168983957219247
Capitalized R&D asset: 3425174.8251748253
ROCI (R&D-adjusted, %): 6.373209976421129
FCF margin (%): 13.052006276619593
Rule of 40 score: 13.052006276619593
Financial ratios for THNC.TO — quarterly report dated 2025-06-30
Total revenue: 13210218.978102189
Gross profit: 9691970.802919708
Operating income: -614598.5401459853
Net income: 271532.84671532846
Capital expenditures: 43795.620437956204
Operating cash flow: 1662773.722627737
Depreciation & amortization: 244525.54744525545
Net tangible assets: 31383211.678832114
Owner earnings: 472262.7737226277
Return on net tangible assets (%): 1.504826142574718
Buffett classification: The Gruesome
Stock price: 1.5109489051094889
P/E ratio: 184.52880374289063
Shares outstanding: 67408713
Book value: 31526277.37226277
P/B ratio: 3.2306738883100645
Market cap (USD): 101851121.10218976
Debt to equity: 0.038526544882035614
Current ratio: 3.1932053804029987
Quick ratio: 3.1932053804029987
COGS to revenue (%): 26.632777102442258
R&D to revenue (%): 29.53917559951376
SG&A to revenue (%): 48.48049508232955
Free cash flow (dilution-adjusted): 702919.7080291971
Buyback yield (%): 1.012641638258505
Retained earnings: -54351824.81751824
Receivables turnover: 3.4783778589275416
Capitalized R&D asset: 6197056.913889031
ROCI (R&D-adjusted, %): 2.1842282054006463
Rosenberg metric: 0.14036713927627242
FCF margin (%): 5.321029948060559
Revenue growth (%): 5.865350474591627
Rule of 40 score: 11.186380422652185